Catalyst Pharmaceuticals, Inc. (CPRX) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
22/25
Growth 5
Margin 4
Expansion 5
Platform 3
Financial 5
latest quarter score
Earnings Reports
- 22
- 20
- 18